-
FARAWAVE Pulsed Field Ablation Catheter and FARASTAR Pulsed Field Ablation Generator System Approved for Marketing
2025-02-19
Recently, the innovative products FARAWAVE Pulsed Field Ablation Catheter and FARASTAR Pulsed Field Ablation Generator System of Farapulse, Inc. is approved for marketing by China NMPA.
-
China's Medical Device Standards Reach 1978 in Total
2025-02-19
Up to now, the number of medical device standards has reached 1978, including 272 national standards and 1706 industry standards; 269 mandatory standards and 1709 recommended standards, basically covering all professional and technical fields of medical devices.
-
Sulbactam Sodium for Injection/Durlobactam Sodium for Injection (co-packaged) Approved for Marketing by China NMPA
2025-02-19
Recently, the Category 1 innovative drug, Sulbactam Sodium for Injection/Durlobactam Sodium for Injection (co-packaged) (trade name: 鼎优乐/XACDURO) of Entasis Therapeutics, Inc. is approved for marketing through the priority review and approval procedure by China NMPA.
-
Ivonescimab Injection Approved for Marketing by China NMPA
2025-02-19
Recently, the Ivonescimab Injection (trade name: 依达方) of Akeso Inc. is approved for marketing through the priority review and approval procedure by China NMPA.
-
Rilertinib Mesylate Tablets Approved for Marketing by China NMPA
2025-02-19
Recently, the Category 1 innovative drug Rilertinib Mesylate Tablets (trade name: 圣瑞沙) of Nanjing Sanhome Pharmaceutical Limited Company is approved for marketing by China NMPA.
-
Envonalkib Citrate Capsules Approved for Marketing by China NMPA
2025-02-19
Recently, the Category 1 innovative drug Envonalkib Citrate Capsules (trade name: 安洛晴) of Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is approved for marketing by China NMPA.
